Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
5AjPQarxDdKQ21zx